Explain Why IV Cetirizine Shouldn’t Be on Formulary

June 2020
IV cetirizine (Quzyttir) will be the first injectable “second-generation” antihistamine.

It will be an IV push...and is approved for acute urticaria. It’s non-inferior to IV diphenhydramine for reducing itching.

Expect reps to tout IV cetirizine as less sedating.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote